Libros: para préstamos o consultas
Los siguientes libros han ingresado en la colección del SACT:
Tietz textook of clinical chemistry and molecular diagnostics
Carl A. Burtis; Edward R. Ashwood; David E. Bruns, directores. - 4a ed. - St. Louis: Elsevier, 2006. - xxxi, 2412 p. - 28 x 22 cm. - ISBN 0-7216-0189-8.
Contenido: Laboratory principles - Analytical techniques and instrumentation - Principles of laboratory medicine - Analytes - Molecular diagnostics and genetics - Pathophysiology - Appendix.
Cardiovascular biomarkers
David A. Marrow - Totowa, New Jersey. Editorial Human Press Inc. 2006 - xvii, 620p : il. col. : 26 x 18,5 cm.
Contiene: Biomarkers of myocardial necrosis: past, present, and future. - Analytical issue for the clinical use of cardiac troponin. - Definig myocardial infarction. - Biomarkers in the emergency department: rapid diagnosis and triage. - Cardiac troponin for risk assessment and management of non-ST-elevation acute coronary syndrome. - Biomarkers of necrosis for risk assessment and management of ST-elevation myocardial infarction. - Cardiac troponin after revascularization procedures. - Biomarkers of necrosis in heart failure: past present, and future directions. - Is there a role for cardiac troponin and other biomarkers in patients with pulmonary embolism?. - Cardiac troponin in conditions others than acute coronary syndromes. - Degradation of cardiac troponins: implications for clinical practice. - Developing a marker of ischemia: Clinical and research challenges. - Emerging biomarkers of myocardial ischemia. - Inflammation in cardiovascular disease: the biological basis of inflammatory biomarkers. - Analytic issues for the clinical use of C-reactive protein. - C-reactive protein as a tool for risk assessment in primary prevention. - High-sensitivity c-reactive protein for risk assessment in acute coronary syndromes. - Beyond c-reactive protein: novel markers of vascular inflammation. - Biomarkers of inflammation: implications in patients with heart failure. - Biomarkers of infection and risk of coronary heart disease. - Biology of the natriuretic peptides. - Analytic issues for the clinical use of B-type natriuretic peptide. - Clinical use of natriuretic peptides for the diagnosis and management of heart failure. - Natriuretic peptides in acute and chronic coronary artery disease. - Novel markers of hemodynamic stress. - Clinical and research applications of markers of thrombosis. - Measures of platelet activation and aggregation. - Monocyte-platelet aggregates in patient with ischemic heart disease. - Measurement of atherogenic lipoproteins in cardiovascular risk assessment. - Lipoprotein-associated phospholipase A2 and other lipid-realted biomarkers in cardiovascular disease. - A multimarker approach to evaluation of patients with acute coronat.
|
|
